A carregar...
Immunogenicity of a peptide‐based anti‐IgE conjugate vaccine in non‐human primates
The anti‐human immunoglobulin E (IgE) monoclonal antibody, omalizumab (Xolair®, Genentech, South San Fransisco, CA), is effective in the treatment of poorly controlled moderate to severe allergic asthma and chronic idiopathic urticaria. It acts by specifically binding to the constant domain (Cϵ3) of...
Na minha lista:
| Publicado no: | Immun Inflamm Dis |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4879460/ https://ncbi.nlm.nih.gov/pubmed/27957325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iid3.98 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|